FLNA
Filana Therapeutics·NASDAQ
--
--(--)
--
--(--)
FLNA Filings
Filing Date
Form Description
Form Type
2026-03-12
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-12 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-12
Form 8-K - Current report
Key Events
2026-03-12 · Key Events
Form 8-K - Current report
2026-03-10
Form 8-K - Current report
Key Events
2026-03-10 · Key Events
Form 8-K - Current report
2026-02-19
Form 8-K - Current report
Key Events
2026-02-19 · Key Events
Form 8-K - Current report
2025-12-23
Form 8-K - Current report
Key Events
2025-12-23 · Key Events
Form 8-K - Current report
2025-12-22
Form 8-K/A - Current report: [Amend]
Key Events
2025-12-22 · Key Events
Form 8-K/A - Current report: [Amend]
2025-12-18
Form 8-K - Current report
Key Events
2025-12-18 · Key Events
Form 8-K - Current report
2025-12-17
Form 8-K - Current report
Key Events
2025-12-17 · Key Events
Form 8-K - Current report
2025-12-08
Form EFFECT - Notice of Effectiveness
2025-12-08 ·
Form EFFECT - Notice of Effectiveness
2025-12-05
Form 424B2 - Prospectus [Rule 424(b)(2)]
2025-12-05 ·
Form 424B2 - Prospectus [Rule 424(b)(2)]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
